Patents by Inventor Matthew Jolly

Matthew Jolly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11548974
    Abstract: A modified polyisobutylene-based polymer, method of making, and a medical device that includes such polymer, wherein the modified polyisobutylene-based polymer includes urethane, urea, or urethane-urea groups, hard segments, and soft segments, wherein the soft segments comprise phenoxy-containing polyisobutylene residues, and the hard segments include diisocyanate residues and optionally chain extender residues.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: January 10, 2023
    Assignee: Medtronic, Inc.
    Inventors: Kimberly A. Chaffin, Xiangji Chen, Matthew Jolly, SuPing Lyu, Peter L. Thor, Darrel F. Untereker, Zhaoxu Wang
  • Publication number: 20210115182
    Abstract: A modified polyisobutylene-based polymer, method of making, and a medical device that includes such polymer, wherein the modified polyisobutylene-based polymer includes urethane, urea, or urethane-urea groups, hard segments, and soft segments, wherein the soft segments comprise phenoxy-containing polyisobutylene residues, and the hard segments include diisocyanate residues and optionally chain extender residues.
    Type: Application
    Filed: December 4, 2020
    Publication date: April 22, 2021
    Inventors: Kimberly A. Chaffin, Xiangji Chen, Matthew Jolly, SuPing Lyu, Peter L. Thor, Darrel F. Untereker, Zhaoxu Wang
  • Publication number: 20210076993
    Abstract: Embodiments of the invention provide compositions useful in implantable devices such as analyte sensors as well as methods for making and using such compositions and devices. In typical embodiments of the invention, the device is a glucose sensor comprising a polymeric composition that includes amounts of one or more immunosuppressant agents so as to provide such membranes with improved material properties such as enhanced biocompatibility.
    Type: Application
    Filed: September 18, 2020
    Publication date: March 18, 2021
    Applicant: Medtronic MiniMed, Inc.
    Inventors: Inthirai Somasuntharam, Jake Matteson, Matthew Jolly, Quyen Ong, Akhil Srinivasan, Poonam Gulati, Andrea Varsavsky, Sana Suhail
  • Patent number: 10882945
    Abstract: A modified polyisobutylene-based polymer, method of making, and a medical device that includes such polymer, wherein the modified polyisobutylene-based polymer includes urethane, urea, or urethane-urea groups, hard segments, and soft segments, wherein the soft segments comprise phenoxy-containing polyisobutylene residues, and the hard segments include diisocyanate residues and optionally chain extender residues.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: January 5, 2021
    Assignee: Medtronic, Inc.
    Inventors: Kimberly A. Chaffin, Xiangji Chen, Matthew Jolly, SuPing Lyu, Peter L. Thor, Darrel F. Untereker, Zhaoxu Wang
  • Publication number: 20190292302
    Abstract: A modified polyisobutylene-based polymer, method of making, and a medical device that includes such polymer, wherein the modified polyisobutylene-based polymer includes urethane, urea, or urethane-urea groups, hard segments, and soft segments, wherein the soft segments comprise phenoxy-containing polyisobutylene residues, and the hard segments include diisocyanate residues and optionally chain extender residues.
    Type: Application
    Filed: March 20, 2019
    Publication date: September 26, 2019
    Inventors: Kimberly A. CHAFFIN, Xiangji CHEN, Matthew JOLLY, SuPing LYU, Peter L. THOR, Darrel F. UNTEREKER, Zhaoxu WANG
  • Publication number: 20190292327
    Abstract: A poly(ether-carbonate)-based polymer and a medical device that includes such polymer, wherein the poly(ether-carbonate)-based polymer includes urethane, urea, or urethane-urea groups, hard segments, and soft segments, wherein the soft segments include poly(ether-carbonate) residues and at least one of polyisobutylene (PIB) residues and hydrogenated polybutadiene residues, and the hard segments include diisocyanate residues and optionally chain extender residues.
    Type: Application
    Filed: March 20, 2019
    Publication date: September 26, 2019
    Inventors: Kimberly A. CHAFFIN, Xiangji CHEN, Matthew JOLLY, SuPing LYU, Peter L. THOR, Darrel F. UNTEREKER, Zhaoxu WANG
  • Publication number: 20160121101
    Abstract: Medical leads, such as medical electrical leads and medical neurological leads, that include a polymeric material that includes a silicone-urethane-containing polymer having improved hydrolytic stability.
    Type: Application
    Filed: December 23, 2015
    Publication date: May 5, 2016
    Inventors: Kimberly A. Chaffin, Matthew Jolly, Darrel F. Untereker, Adam J. Buckalew, Xiangji Chen, Thomas P. Grailer, Julie Alkatout
  • Patent number: 9220888
    Abstract: Medical leads, such as medical electrical leads and medical neurological leads, that include a polymeric material that includes a silicone-urethane-containing polymer having improved hydrolytic stability.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: December 29, 2015
    Assignee: Medtronic, Inc.
    Inventors: Kimberly A. Chaffin, Matthew Jolly, Darrel F. Untereker, Adam J. Buckalew, Xiangji Chen, Thomas P. Grailer, Julie Alkatout
  • Publication number: 20130261715
    Abstract: Medical leads, such as medical electrical leads and medical neurological leads, that include a polymeric material that includes a silicone-urethane-containing polymer having improved hydrolytic stability.
    Type: Application
    Filed: March 7, 2013
    Publication date: October 3, 2013
    Inventors: Kimberly A. Chaffin, Matthew Jolly, Darrel F. Untereker, Adam J. Buckalew, Xiangji Chen, Thomas P. Grailer, Julie Alkatout
  • Publication number: 20120277748
    Abstract: A plate for connecting a first portion of bone and a second portion of bone is disclosed. The plate comprises a central longitudinal axis, a first end portion extending along the central longitudinal axis and configured to affix to the first portion of bone, a second end portion extending along the central longitudinal axis and configured to affix to the second portion of bone, and an intermediary portion extending along the central longitudinal axis and between the first end portion and the second end portion. The intermediary portion comprises three continuous segments of material, two segments of which extend along a direction substantially parallel to the central longitudinal axis, and one segment of which extends along a direction substantially perpendicular to the central longitudinal axis.
    Type: Application
    Filed: April 28, 2011
    Publication date: November 1, 2012
    Applicant: Warsaw Orthopedic, Inc.
    Inventors: Paul Trescony, Jeffrey Rouleau, Matthew Jolly
  • Publication number: 20100196439
    Abstract: Various methods and devices are provided for providing therapy to a living body. In one embodiment, an implanted permeable container has living cells provided therein, and various nutrients and/or agents are provided into the container to promote cell life.
    Type: Application
    Filed: December 20, 2007
    Publication date: August 5, 2010
    Applicant: Medtronic, Inc.
    Inventors: Michael Theodore Beck, Deon Bezuidenhout, Kelvin Bonnema, Kimberly A. Chaffin, Neil Davies, Brian C.A. Fernandes, Eric J. Fogt, Eric A. Grovender, Robert Cushing Hamlen, Matthew Jolly, Eamonn J. McAndrew, Syamasundar V. Pakala, William P. VanAntwerp, Peter P. Zilla, Edouard A. Koullick
  • Publication number: 20090105811
    Abstract: Disclosed herein are vascular cell encapsulation devices that can deliver cell type(s) for the treatment of a disease or disorder.
    Type: Application
    Filed: October 20, 2008
    Publication date: April 23, 2009
    Applicant: Medtronic, Inc.
    Inventors: Thomas Q. Dinh, Rodolfo A. Padua, Syamasundar V. Pakala, Matthew Jolly